FindTrial
Sign In

Application of metagenomic sequencing in diagnosis of peritoneal infection with Ureaplasma parvum combined with novel coronavirus

Application of metagenomic sequencing in diagnosis of peritoneal infection with Ureaplasma parvum combined with novel coronavirus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120155
Enrollment
Unknown
Registered
2026-03-10
Start date
2026-03-15
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritoneal Dialysis-Associated Peritonitis

Interventions

Peritoneal dialysis group with Mycoplasma hominis infection:NA

Sponsors

Yuebei People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnosis of peritoneal dialysis-associated peritonitis (PDAP). 2. Received metagenomic sequencing (mNGS) of ascites during hospitalization. 3. Concurrent COVID-19 infection during hospitalization.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Clinical response after treatment regimen adjustment based on mNGS resul;Comparison of pathogen detection results between mNGS and traditional microbial culture (ascites culture, blood culture).;—

Secondary

MeasureTime frame
Total length of hospital stay and incidence of complications (such as catheter removal);Dynamic changes of inflammatory markers (PCT, WBC);—

Countries

China

Contacts

Public ContactHelin Zhang

Yuebei People’s Hospital

helinzh@126.com+86 851 6913467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026